Epidural Electrical Stimulation for Stroke Patients - Improve Motor and Sensory Function and Alleviate Pain

ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-70
SponsorBuddhist Tzu Chi General Hospital

About this trial

This study aims to verify whether epidural electrical stimulation (EES) of the cervical spinal cord can activate muscles of the upper limbs in people with hemiplegia following a stroke.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Between 20 and 70 years of age

First-ever clinical manifest stroke

Right or left hemiparesis

Scores higher than 7 and lower than 45 on the Fugl-Meyer scale.

Disqualifiers

Pregnancy or breast feeding.

Have Major depressive disorder.

Had a mental illness within one year or been treated in the past.

Have significant cognitive impairment (MMSE<24) or serious disease that could affect the ability to participate in study activities.

Trial design

Design model

Single group

Treatments tested in this trial

  • Epidural electrical stimulation (EES)

    Device

    Subjects will undergo a surgical procedure to implant a system that provides epidural electrical stimulation (EES) of the cervical spinal cord. After surgery, subjects will undergo a structured physical rehabilitation program and electrical stimulation.

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: Epidural electrical stimulation (EES)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in motor functioning and sensation as measured by the Fugl-Meyer Assessment (FMA)

The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is main assesses motor functioning and sensation in patients with post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, describe motor recovery, and plan and assess treatment. The upper extremity motor function score ranges from 0 to 66.

Time frame
Time Frame: Baseline; at 1 - 4 - 7 - 13 - 19 - 25 months after the implantation
2

Change dexterity of the upper limb as measured by the Action Research Arm Test (ARAT)

Use the Action Research Arm Test (ARAT) assessment to quantify functional hand and arm dexterity. The score ranges from 0 to 57, with a higher value indicating better function.

Time frame
Time Frame: Baseline; at 1 - 4 - 7 - 13 - 19 - 25 months after the implantation

Secondary outcomes

1

Change in Quality of Life (QOL) as measured by the World Health Organization Quality of Life (WHOQOL-BREF)

The WHOQOL-BREF is a self-administered questionnaire comprising 26 questions on the individual's perceptions of their health and well-being over the previous two weeks. Responses to questions are on a 1-5 Likert scale where 1 represents "disagree" or "not at all" and 5 represents "completely agree" or "extremely". , The higher the score, the better the quality of life

Time frame
Baseline; at 1 - 4 - 7 - 13 - 19 - 25 months after implantation
2

Change in spasticity as measured by the Modified Ashworth Scale (MAS)

Quantify spasticity scores using the Modified Ashworth Scale (MAS) for the shoulder, elbow, and wrist. The muscle tension is divided into 0-4 grades. The lower the score, the closer to normal. The higher the score, the more severe the spasticity.

Time frame
Time Frame: Baseline; at 1 - 4 - 7 - 13 - 19 - 25 months after the implantation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.